ALKBH3 and hepatocellular carcinoma: Moreover, survival analysis of TCGA‐LIHC data using the GEPIA platform18 confirmed that the higher level of ALKBH3‐AS1 predicts the poorer survival of HCC (p < 0.05, Figure 1F).